Skip to main content
. 2017 Oct 28;9(11):317. doi: 10.3390/v9110317

Figure 4.

Figure 4

(a) Strong reaction of a Cytotect preparation against the recombinant gB proteins R1 and R2 of PCMV. 1, marker, 2, anti-His-tag antibody 1:1000, anti-mouse antibodies 1:1000 as positive controls, 3–9, dilution of the Cytotect preparation starting with 1:50, anti-human antibodies 1:1000; (b) left, reaction of the Cytotect preparation (1:50) with the gB proteins R1 and R2, and two tegument proteins of PCMV, UA, and UB; right, negative control, secondary human antibody 1:1000 only.